A multifunctional peptide rescues memory deficits in Alzheimer's disease transgenic mice by inhibiting Aβ42-induced cytotoxicity and increasing microglial phagocytosis

A multifunctional peptide rescues memory deficits in Alzheimer's disease transgenic mice by inhibiting Aβ42-induced cytotoxicity and increasing microglial phagocytosis

Alzheimer's disease (AD) is characterized by progressive memory loss due to extracellular senile plaques and intracellular neurofibrillary tangles. The toxic β-amyloid (Aβ) aggregates that form in AD can induce the overproduction of reactive oxygen species (ROS), nitric oxide (NO), and proinfla...

Full description

Bibliographic Details
Main Authors:	Di Xue, Min Zhao, Yu-jiong Wang, Li Wang, Yang Yang, Shao-wei Wang, Ran Zhang, Yang Zhao, Rui-tian Liu
Format:	Article
Language:	English
Published:	Elsevier 2012-06-01
Series:	Neurobiology of Disease
Subjects:	Alzheimer's disease β-Amyloid Peptide Cytotoxicity Memory deficits Aβ clearance
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996112000848

Similar Items

Identification of methylation-regulated genes modulating microglial phagocytosis in hyperhomocysteinemia-exacerbated Alzheimer’s disease
by: Xianwei Wang, et al.
Published: (2023-10-01)

Far infrared light irradiation enhances Aβ clearance via increased exocytotic microglial ATP and ameliorates cognitive deficit in Alzheimer’s disease-like mice
by: Qingyong Li, et al.
Published: (2022-06-01)

The Aβ protofibril selective antibody mAb158 prevents accumulation of Aβ in astrocytes and rescues neurons from Aβ-induced cell death
by: Sofia Söllvander, et al.
Published: (2018-03-01)

Alginate-Derived Oligosaccharide Inhibits Neuroinflammation and Promotes Microglial Phagocytosis of β-Amyloid
by: Rui Zhou, et al.
Published: (2015-09-01)

Systematic characterization of a non-transgenic Aβ 1–42 amyloidosis model: synaptic plasticity and memory deficits in female and male mice
by: Raquel Jiménez-Herrera, et al.
Published: (2023-09-01)

The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets
by: Xue-mei Qi, et al.
Published: (2017-08-01)

Rescue of cognitive deficits in APP/PS1 mice by accelerating the aggregation of β-amyloid peptide
by: Jian-Xiang Zhang, et al.
Published: (2019-12-01)

Catalpol rescues cognitive deficits by attenuating amyloid β plaques and neuroinflammation
by: Si Li, et al.
Published: (2023-09-01)

New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer’s Disease
by: Botond Penke, et al.
Published: (2023-03-01)

BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice
by: Masuo Ohno, et al.
Published: (2007-04-01)

Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice
by: Wenjuan Yang, et al.
Published: (2018-06-01)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
by: Noelia Fandos, et al.
Published: (2017-01-01)

Night Photostimulation of Clearance of Beta-Amyloid from Mouse Brain: New Strategies in Preventing Alzheimer’s Disease
by: Oxana Semyachkina-Glushkovskaya, et al.
Published: (2021-11-01)

Chronic neuroinflammation impairs waste clearance in the rat brain
by: Swathi Suresh, et al.
Published: (2022-12-01)

The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer’s disease
by: Tunahan Kirabali, et al.
Published: (2019-12-01)

Evidence for a Strong Relationship between the Cytotoxicity and Intracellular Location of β-Amyloid
by: Md. Aminul Haque, et al.
Published: (2022-04-01)

Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42
by: Seong Soo A. An, et al.
Published: (2017-10-01)

Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer’s disease
by: Xiao Zhang, et al.
Published: (2021-05-01)

Pharmacological Stimulation of Phagocytosis Enhances Amyloid Plaque Clearance; Evidence from a Transgenic Mouse Model of ATTR Neuropathy
by: Eleni Fella, et al.
Published: (2017-05-01)

Redox-Dependent Copper Ion Modulation of Amyloid-β (1-42) Aggregation In Vitro
by: Nima Sasanian, et al.
Published: (2020-06-01)

Callistephin inhibits amyloid-β protein aggregation and determined cytotoxicity against cerebrovascular smooth muscle cells as an in vitro model of cerebral amyloid angiopathy
by: E. Ruifang, et al.
Published: (2022-02-01)

A Systematic Screening of Traditional Chinese Medicine Identifies Two Novel Inhibitors Against the Cytotoxic Aggregation of Amyloid Beta
by: Liang Ma, et al.
Published: (2021-04-01)

Photostimulation of lymphatic clearance of β-amyloid from mouse brain: a new strategy for the therapy of Alzheimer’s disease
by: Dongyu Li, et al.
Published: (2023-12-01)

Glymphatic system, AQP4, and their implications in Alzheimer’s disease
by: Inês Silva, et al.
Published: (2021-01-01)

Gallic acid disruption of Aβ1–42 aggregation rescues cognitive decline of APP/PS1 double transgenic mouse
by: Mei Yu, et al.
Published: (2019-04-01)

A spectrum of exercise training reduces soluble Aβ in a dose-dependent manner in a mouse model of Alzheimer's disease
by: Kaitlin M. Moore, et al.
Published: (2016-01-01)

GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment
by: Yilan Xu, et al.
Published: (2020-06-01)

The Interplay Between Beta-Amyloid 1–42 (Aβ1–42)-Induced Hippocampal Inflammatory Response, p-tau, Vascular Pathology, and Their Synergistic Contributions to Neuronal Death and Behavioral Deficits
by: Beatriz Calvo-Flores Guzmán, et al.
Published: (2020-11-01)

Manganese Exposure Aggravates β-Amyloid Pathology by Microglial Activation
by: Geng Lin, et al.
Published: (2020-11-01)

Conformational Essentials Responsible for Neurotoxicity of Aβ42 Aggregates Revealed by Antibodies against Oligomeric Aβ42
by: Chuli Song, et al.
Published: (2022-10-01)

H2O2‐responsive multifunctional nanocomposite for the inhibition of amyloid‐β and Tau aggregation in Alzheimer's disease
by: Luying Qiao, et al.
Published: (2023-03-01)

Influenza vaccination in early Alzheimer’s disease rescues amyloidosis and ameliorates cognitive deficits in APP/PS1 mice by inhibiting regulatory T cells
by: Yunjie Yang, et al.
Published: (2020-02-01)

The <i>TREM2</i> H157Y Variant Influences Microglial Phagocytosis, Polarization, and Inflammatory Cytokine Release
by: Xin-Xin Fu, et al.
Published: (2023-04-01)

Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
by: Oliver Wirths, et al.
Published: (2020-10-01)

Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to β-amyloid deposition in APP/PS1 double transgenic Alzheimer mice
by: Tarja M. Malm, et al.
Published: (2005-02-01)

SNX8 Enhances Non-amyloidogenic APP Trafficking and Attenuates Aβ Accumulation and Memory Deficits in an AD Mouse
by: Yongzhuang Xie, et al.
Published: (2019-09-01)

The Influence of Lipid Electric Charge on the Binding of Aβ(1–42) Amyloid Peptide to Bilayers in the Liquid-Ordered State
by: Hasna Ahyayauch, et al.
Published: (2024-03-01)

Interaction between therapeutic interventions for Alzheimer’s disease and physiological Aβ clearance mechanisms
by: Christopher eMorrone, et al.
Published: (2015-05-01)

Folate Deficiency Increased Microglial Amyloid-β Phagocytosis via the RAGE Receptor in Chronic Unpredictable Mild-Stress Rat and BV2 Cells
by: Junting Fan, et al.
Published: (2023-08-01)

Evaluation of Amyloid β<sub>42</sub> Aggregation Inhibitory Activity of Commercial Dressings by A Microliter-Scale High-Throughput Screening System Using Quantum-Dot Nanoprobes
by: Masahiro Kuragano, et al.
Published: (2020-06-01)